Zoetis Inc. (VIE:ZOTS)

Market Cap	47.59B
Revenue (ttm)	8.01B
Net Income (ttm)	2.26B
Shares Out	n/a
EPS (ttm)	5.06
PE Ratio	21.06
Forward PE	19.15
Dividend	1.78 (1.66%)
Ex-Dividend Date	Oct 31, 2025

Volume	n/a
Average Volume	7
Open	107.68
Previous Close	108.26
Day's Range	107.16 - 107.98
52-Week Range	99.76 - 172.22
Beta	n/a
RSI	49.56
Earnings Date	Feb 13, 2026

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ZOTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD